News | January 13, 2009

Ablation Increasingly Being Used to Treat Atrial Fibrillation

January 14, 2009 - According to Millennium Research Group's (MRG's) U.S. Markets for Electrophysiology (EP) Mapping and Ablation Devices 2009 report, an increase in the number of catheter ablation procedures for treating atrial fibrillation (AF) will fuel revenues in the EP ablation catheter market over the next five years.

The ablation catheter market will exhibit strong growth from 2008 to 2013, at a compound annual rate of almost 14 percent, exceeding $480 million by the end of 2013, MRG said.

With the increased clinical attention AF is generating, market competitors are increasingly targeting their product development efforts towards designing AF-specific catheters. The pending U.S. approval of the first AF-indicated ablation catheter is expected to be the first of many devices to earn this designation.

In November 2008, an FDA advisory panel voted to expand the label for Biosense Webster's NaviStar ThermoCool radiofrequency ablation catheter to include an indication for AF. Several other manufacturers are also pursuing AF approval for their devices. CryoCath (acquired by Medtronic in Q3 2008) and Ablation Frontiers are developing ablation catheters specifically designed for cardiac anatomy associated with AF.

“A number of leading competitors are developing therapeutic solutions for treating AF safely and effectively," says Anuk Karunaratne, snior analyst at MRG. “Currently, only a small percentage of patients with AF are treated with catheter ablation, but by 2013 this percentage will have tripled, and AF-indicated devices will be in a strong position to gain share of these procedures”

MRG's U.S. Markets for Electrophysiology Mapping and Ablation Devices 2009 report provides coverage of key industry competitors, including Biosense Webster, Boston Scientific, GE Healthcare, Siemens Healthcare, St. Jude Medical, and more.

With an estimated prevalence approaching 3.2 million in the U.S. in 2008, AF is the most common clinically significant cardiac arrhythmia. AF causes up to a 30 percent reduction in cardiac output, leading to shortness of breath and fatigue. AF is also a significant risk factor for stroke because blood pools form in the atria as a result of inefficient pumping, which then increases the likelihood of clot formation.

For more information: www.mrg.net

Related Content

Boston Scientific to Acquire Cryterion Medical Inc.
News | Ablation Systems | July 13, 2018
Boston Scientific Corp. recently announced a definitive agreement to acquire Cryterion Medical Inc., a privately-held...
Treating AFib With Ablation Reduces Mortality and Stroke
News | Ablation Systems | July 05, 2018
Using catheter-based ablation instead of medications alone reduces the risks of death and stroke in patients with the...
LuxCath Showcases OmniView Light-Guided Ablation Catheter at HRS 2018
News | Ablation Systems | May 22, 2018
LuxCath LLC showcased the next generation of its proprietary OmniView light-guided catheter ablation system at the 2018...
The Kardium Globe combined mapping and ablation catheter. The device has a distal multi-electrode array consisting of 16 ribs with 122 gold-plated electrodes. Ablation can be done with up to 24 electrodes simultaneously.  #HRS2018

The Kardium Globe combined mapping and ablation catheter. The device has a distal multi-electrode array consisting of 16 ribs with 122 gold-plated electrodes. Ablation can be done with up to 24 electrodes simultaneously. 

News | Ablation Systems | May 21, 2018
May 21, 2018 — Complete pulmonary vein isolation (PVI) was achieved in more than 99 percent of patients in a first-in
CardioFocus Announces Successful Live Case Featuring HeartLight X3 System
News | Ablation Systems | May 17, 2018
Medical device manufacturer CardioFocus Inc. announced a successful live case featuring its HeartLight X3 System during...
Imricor MRI-Guided Cardiac Ablation Study Results to Be Presented at HRS 2018
News | Ablation Systems | May 10, 2018
Results from the clinical study to evaluate Imricor’s Vision-MR Ablation Catheter for the treatment of atrial flutter...
Biosense Webster Launches Carto Vizigo Bi-Directional Guidance Sheath
Technology | Ablation Systems | May 08, 2018
Biosense Webster Inc. announced its Carto Vizigo Bi-directional Guiding Sheath is now available in the United States....
Stereotaxis and Acutus Medical Announce Strategic Collaboration
News | Ablation Systems | May 04, 2018
Stereotaxis and Acutus Medical announced a strategic collaboration to integrate the Stereotaxis Niobe Magnetic...
Medtronic Cryoballoon Shows Positive Results for Patients With Persistent Atrial Fibrillation
News | Ablation Systems | April 12, 2018
Medtronic plc announced one-year results from the CRYO4PERSISTENT AF study of ablation with the Arctic Front Advance...
Boston Scientific Acquires Securus Medical Group Inc.
News | Ablation Systems | April 04, 2018
Boston Scientific Corp. announced the acquisition of Securus Medical Group Inc., a privately-held company that has...
Overlay Init